IT1398553B1 - Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario. - Google Patents

Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario.

Info

Publication number
IT1398553B1
IT1398553B1 ITMI2010A000375A ITMI20100375A IT1398553B1 IT 1398553 B1 IT1398553 B1 IT 1398553B1 IT MI2010A000375 A ITMI2010A000375 A IT MI2010A000375A IT MI20100375 A ITMI20100375 A IT MI20100375A IT 1398553 B1 IT1398553 B1 IT 1398553B1
Authority
IT
Italy
Prior art keywords
alteration
treatment
immune system
composition including
probiotic bacteria
Prior art date
Application number
ITMI2010A000375A
Other languages
English (en)
Inventor
Lorenzo Drago
Giovanni Mogna
Gian Paolo Strozzi
Luca Mogna
Original Assignee
Probiotical Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ITMI2010A000375A priority Critical patent/IT1398553B1/it
Application filed by Probiotical Spa filed Critical Probiotical Spa
Priority to RU2016129186A priority patent/RU2712751C9/ru
Priority to HUE13166218A priority patent/HUE030888T2/en
Priority to CN201510082517.4A priority patent/CN104800247A/zh
Priority to KR1020127026327A priority patent/KR101872946B1/ko
Priority to US13/583,477 priority patent/US8734783B2/en
Priority to RU2012140052/15A priority patent/RU2605293C2/ru
Priority to ES13166218.1T priority patent/ES2603629T3/es
Priority to CA2792343A priority patent/CA2792343C/en
Priority to JP2012556603A priority patent/JP5931754B2/ja
Priority to AU2011225798A priority patent/AU2011225798B2/en
Priority to PT117177329T priority patent/PT2544698T/pt
Priority to CN201180019385.0A priority patent/CN103037876B/zh
Priority to BR112012022755-6A priority patent/BR112012022755B1/pt
Priority to DK11717732.9T priority patent/DK2544698T3/en
Priority to PT131662181T priority patent/PT2626076T/pt
Priority to PCT/IB2011/000490 priority patent/WO2011110918A1/en
Priority to PL11717732T priority patent/PL2544698T3/pl
Priority to DK13166218.1T priority patent/DK2626076T3/en
Priority to HUE11717732A priority patent/HUE029245T2/en
Priority to EP11717732.9A priority patent/EP2544698B1/en
Priority to EP13166218.1A priority patent/EP2626076B1/en
Priority to ES11717732.9T priority patent/ES2581803T3/es
Priority to PL13166218T priority patent/PL2626076T3/pl
Priority to UAA201211024A priority patent/UA111715C2/uk
Publication of ITMI20100375A1 publication Critical patent/ITMI20100375A1/it
Priority to ZA2012/07377A priority patent/ZA201207377B/en
Publication of IT1398553B1 publication Critical patent/IT1398553B1/it
Application granted granted Critical
Priority to US14/286,308 priority patent/US9498503B2/en
Priority to ZA2014/09369A priority patent/ZA201409369B/en
Priority to JP2016029244A priority patent/JP6182628B2/ja
Priority to US15/294,464 priority patent/US9931363B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/181—Salivarius
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
ITMI2010A000375A 2010-03-08 2010-03-08 Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario. IT1398553B1 (it)

Priority Applications (30)

Application Number Priority Date Filing Date Title
ITMI2010A000375A IT1398553B1 (it) 2010-03-08 2010-03-08 Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario.
PL13166218T PL2626076T3 (pl) 2010-03-08 2011-03-07 Zastosowania terapeutyczne Lactobacillus salivarius LS01 DSM 22775
CN201510082517.4A CN104800247A (zh) 2010-03-08 2011-03-07 用于治疗免疫病症的包含益生菌的组合物及其应用
KR1020127026327A KR101872946B1 (ko) 2010-03-08 2011-03-07 면역질환의 치료에 사용하기 위한 프로바이오틱 박테리아를 포함하는 조성물
US13/583,477 US8734783B2 (en) 2010-03-08 2011-03-07 Composition comprising probiotic bacteria for use in the treatment of immune disorders
RU2012140052/15A RU2605293C2 (ru) 2010-03-08 2011-03-07 Композиция, содержащая пробиотические бактерии, для применения в лечении иммунных расстройств
PL11717732T PL2544698T3 (pl) 2010-03-08 2011-03-07 Kompozycja zawierająca bakterie probiotyczne do zastosowania w leczeniu zaburzeń odporności
CA2792343A CA2792343C (en) 2010-03-08 2011-03-07 Composition comprising probiotic bacteria for use in the treatment of immune disorders
JP2012556603A JP5931754B2 (ja) 2010-03-08 2011-03-07 免疫疾患の処置において使用するための、プロバイオティック細菌を含む組成物
AU2011225798A AU2011225798B2 (en) 2010-03-08 2011-03-07 Composition comprising probiotic bacteria for use in the treatment of immune disorders
PT117177329T PT2544698T (pt) 2010-03-08 2011-03-07 Composição contendo bactérias probióticas para utilização no tratamento de distúrbios imunitários
CN201180019385.0A CN103037876B (zh) 2010-03-08 2011-03-07 用于治疗免疫病症的包含益生菌的组合物
BR112012022755-6A BR112012022755B1 (pt) 2010-03-08 2011-03-07 composição com bactérias probióticas para uso no tratamento de distúrbios imunológicos
DK11717732.9T DK2544698T3 (en) 2010-03-08 2011-03-07 Composition comprising probiotic bacteria for use in treatment of immune disorders
RU2016129186A RU2712751C9 (ru) 2010-03-08 2011-03-07 Композиция, содержащая пробиотические бактерии, для применения в лечении иммунных расстройств
PT131662181T PT2626076T (pt) 2010-03-08 2011-03-07 Utilizações terapêuticas de lactobacillus salivarus ls01 22775
ES13166218.1T ES2603629T3 (es) 2010-03-08 2011-03-07 Usos terapéuticos de Lactobacillus salivarius LS01 DSM 22775
DK13166218.1T DK2626076T3 (en) 2010-03-08 2011-03-07 Therapeutic uses of Lactobacillus salivarius DSM 22775 LS01
HUE11717732A HUE029245T2 (en) 2010-03-08 2011-03-07 Probiotic bacterial composition for use in the treatment of immune disorders
EP11717732.9A EP2544698B1 (en) 2010-03-08 2011-03-07 Composition comprising probiotic bacteria for use in the treatment of immune disorders
EP13166218.1A EP2626076B1 (en) 2010-03-08 2011-03-07 Therapeutic uses of Lactobacillus salivarius LS01 DSM 22775
ES11717732.9T ES2581803T3 (es) 2010-03-08 2011-03-07 Composición que comprende bacterias probióticas para su uso en el tratamiento de trastornos inmunitarios
HUE13166218A HUE030888T2 (en) 2010-03-08 2011-03-07 Therapeutic applications of Lactobacillus salivarius (LS01) DSM 22775
PCT/IB2011/000490 WO2011110918A1 (en) 2010-03-08 2011-03-07 Composition comprising probiotic bacteria for use in the treatment of immune disorders
UAA201211024A UA111715C2 (uk) 2010-03-08 2011-07-03 Композиція, що містить пробіотичні бактерії для застосування у лікуванні імунних розладів
ZA2012/07377A ZA201207377B (en) 2010-03-08 2012-10-02 Composition comprising probiotic bacteria for use in the treatment of immune disorders
US14/286,308 US9498503B2 (en) 2010-03-08 2014-05-23 Composition comprising probiotic bacteria for use in the treatment of immune disorders
ZA2014/09369A ZA201409369B (en) 2010-03-08 2014-12-18 Composition comprising probiotic bacteria for the treatment of pathologies associated with alterations of the immune system
JP2016029244A JP6182628B2 (ja) 2010-03-08 2016-02-18 免疫疾患の処置において使用するための、プロバイオティック細菌を含む組成物
US15/294,464 US9931363B2 (en) 2010-03-08 2016-10-14 Composition comprising probiotic bacteria for use in the treatment of immune disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI2010A000375A IT1398553B1 (it) 2010-03-08 2010-03-08 Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario.

Publications (2)

Publication Number Publication Date
ITMI20100375A1 ITMI20100375A1 (it) 2011-09-09
IT1398553B1 true IT1398553B1 (it) 2013-03-01

Family

ID=42942117

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI2010A000375A IT1398553B1 (it) 2010-03-08 2010-03-08 Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario.

Country Status (18)

Country Link
US (3) US8734783B2 (it)
EP (2) EP2626076B1 (it)
JP (2) JP5931754B2 (it)
KR (1) KR101872946B1 (it)
CN (2) CN104800247A (it)
AU (1) AU2011225798B2 (it)
BR (1) BR112012022755B1 (it)
CA (1) CA2792343C (it)
DK (2) DK2544698T3 (it)
ES (2) ES2581803T3 (it)
HU (2) HUE029245T2 (it)
IT (1) IT1398553B1 (it)
PL (2) PL2626076T3 (it)
PT (2) PT2626076T (it)
RU (2) RU2605293C2 (it)
UA (1) UA111715C2 (it)
WO (1) WO2011110918A1 (it)
ZA (2) ZA201207377B (it)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1398553B1 (it) * 2010-03-08 2013-03-01 Probiotical Spa Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario.
WO2011149335A1 (en) * 2010-05-25 2011-12-01 N.V. Nutricia Immune imprinting nutritional composition
IT1403661B1 (it) 2011-01-28 2013-10-31 Probiotical Spa Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
ITRM20110477A1 (it) 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
US9173910B2 (en) 2012-02-29 2015-11-03 The General Hospital Corporation Compositions of microbiota and methods related thereto
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
ITMI20122270A1 (it) * 2012-12-31 2014-07-01 Giovanni Mogna Terapia di supporto ai trattamenti di chemioterapia per i tumori, per la sindrome da immunodeficienza acquisita e per le leucemie.
EP3904502A3 (en) 2013-02-04 2022-02-23 Seres Therapeutics, Inc. Compositions and methods
EP3584308A3 (en) 2013-02-04 2020-03-04 Seres Therapeutics, Inc. Compositions and methods
CA2906921A1 (en) 2013-03-15 2014-09-18 Seres Therapeutics, Inc. Network-based microbial compositions and methods
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
FR3004349B1 (fr) * 2013-04-15 2015-11-27 Greentech Applications cosmetiques et pharmaceutiques de lactobacillus pentosus
ITMI20130793A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
ITMI20130795A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici e/o bifidobatteri per uso nel trattamento preventivo e/o curativo delle infezioni batteriche e/o delle infiammazioni del tratto urinario e/o della prostata che sono la causa di prostatiti e ipertrofia prostat
US10165788B2 (en) * 2013-06-17 2019-01-01 The Regents Of The University Of California Methods and compositions for improved digestion of milk oligosaccharides
MX367109B (es) 2013-11-25 2019-08-05 Seres Therapeutics Inc Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
EP3082431A4 (en) * 2013-12-16 2017-11-15 Seres Therapeutics, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
EP3212001A4 (en) 2014-10-31 2018-04-25 Whole Biome Inc. Methods and compositions relating to microbial treatment and diagnosis of disorders
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
WO2016084029A1 (en) * 2014-11-26 2016-06-02 Probiotical S.P.A. Strains of lactobacillus or bifidobacterium for maintaining homeostasis
JP6427278B2 (ja) 2014-12-23 2018-11-21 フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ ｐｉｒｉｎポリペプチド及び免疫モジュレーション
CN108138122B (zh) 2014-12-23 2021-09-21 4D制药研究有限公司 免疫调控
DK3240426T3 (da) 2014-12-29 2019-07-22 Mofin S R L Fremstilling af en gærfri, meget fordøjelig pizza ved anvendelse af en dej indeholdende mælkesyrebakterier
SG10201912319SA (en) * 2015-06-15 2020-02-27 4D Pharma Res Ltd Compositions comprising bacterial strains
HUE045413T2 (hu) 2015-06-15 2019-12-30 4D Pharma Res Ltd Baktériumtörzseket tartalmazó készítmények
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
DK3240554T3 (da) 2015-06-15 2019-10-28 4D Pharma Res Ltd Blautia stercosis og wexlerae til anvendelse til behandling af inflammatoriske og autoimmune sygdomme
ITUB20155700A1 (it) * 2015-11-18 2017-05-18 Probiotical Spa Composizioni con azione sinergica tra un complesso gelificante muco-aderente contro il passaggio degli antigeni, e batteri immunomodulanti anti-IL17 per uso nel trattamento delle malattie autoimmuni e neurodegenerative IL17 dipendenti.
ITUB20155752A1 (it) * 2015-11-19 2017-05-19 Probiotical Spa Composizione di batteri per uso per attenuare le diminuzioni di prestazione dopo un esercizio fisico che danneggia i muscoli.
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
NZ742787A (en) 2015-11-20 2020-02-28 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
JP6347268B2 (ja) * 2016-02-26 2018-06-27 トヨタ自動車株式会社 複合活物質の製造方法
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
ES2731579T3 (es) 2016-03-04 2019-11-18 4D Pharma Plc Composiciones que comprenden cepas de blautia bacteriana para tratar hipersensibilidad visceral
ITUA20164065A1 (it) * 2016-06-01 2017-12-01 Probiotical Spa Composizioni in gel per applicazioni topiche a base di batteri, preparazione delle stesse e loro usi.
TW201821093A (zh) 2016-07-13 2018-06-16 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
RS61872B1 (sr) 2017-05-22 2021-06-30 4D Pharma Res Ltd Kompozicije koje sadrže bakterijske sojeve
JP6978514B2 (ja) 2017-05-24 2021-12-08 フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited 細菌株を含む組成物
KR102205829B1 (ko) 2017-06-14 2021-01-21 기초과학연구원 신규한 비피도박테리움 비피덤 균주 및 균주 유래 다당체
PT3638271T (pt) 2017-06-14 2021-01-05 4D Pharma Res Ltd Composições contendo estirpes bacterianas
HRP20220747T1 (hr) 2017-06-14 2022-10-14 4D Pharma Research Limited Pripravci koji sadrže bakterijske sojeve
JP2020530840A (ja) 2017-08-14 2020-10-29 セレス セラピューティクス インコーポレイテッド 胆汁うっ滞性疾患を治療するための組成物及び方法
RU2699540C2 (ru) * 2017-08-17 2019-09-06 Павел Павлович Несмиянов Композиция, содержащая пробиотические бактерии или их компоненты, и способ ее применения в лечении иммунных заболеваний кожи
EP3675882A4 (en) 2017-08-30 2021-07-28 Pendulum Therapeutics, Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
CN110710627A (zh) * 2018-07-12 2020-01-21 序瑞生物科技(上海)有限公司 一种功能性益生菌固体饮料及其制备方法
KR102130646B1 (ko) * 2018-10-15 2020-07-06 주식회사 제일바이오 신규한 락토바실러스 살리바리우스 및 이를 유효성분으로 포함하는 양식 어류 및 갑각류용 사료첨가제
WO2020178794A1 (en) * 2019-03-07 2020-09-10 Probiotical S.P.A. Mixture of probiotic bacteria strains for use in the treatment of allergic asthma and with recurrent wheezing, preferably in paediatric subjects
CN110616167B (zh) * 2019-08-22 2022-02-01 江南大学 能够缓解特应性皮炎的双歧杆菌及其应用
CN110643541B (zh) * 2019-10-25 2021-08-24 江南大学 一株可调节过敏性哮喘Th2/Th1平衡的干酪乳杆菌及其应用
WO2021138599A1 (en) * 2020-01-03 2021-07-08 Forte Subsidiary, Inc. Cosmetic compositions
KR102152878B1 (ko) * 2020-03-02 2020-09-07 주식회사 잇츠한불 락토바실러스 펜토서스 균주 및 이를 포함하는 미생물 균총 개선 및 피부 장벽 개선용 조성물
CN111528479A (zh) * 2020-05-15 2020-08-14 深圳爱米基因科技有限责任公司 一种缓解特应性皮炎功能的益生菌和益生元组合物及应用
CN111700917B (zh) * 2020-06-18 2022-08-09 江南大学 一种用于预防和/或治疗特应性皮炎的产品
CN111840335A (zh) * 2020-07-07 2020-10-30 刘平祥 一种含有益生菌的组合物及其在气管炎哮喘上的应用
AU2021319291A1 (en) * 2020-07-31 2023-03-23 Synbalance Srl Probiotic compositions and their use to modulate immune systems
IT202000018901A1 (it) * 2020-07-31 2022-01-31 Synbalance Srl Composizioni probiotiche e loro uso nella prevenzione e/o nel trattamento di patologie e/o disturbi della pelle
CN114317320B (zh) 2020-08-24 2022-12-27 汤臣倍健股份有限公司 一种短双歧杆菌207-1及其应用
CN114304642A (zh) * 2021-11-25 2022-04-12 青岛康益生物科技有限公司 一种用于过敏的益生菌产品
CN115428954A (zh) * 2022-09-15 2022-12-06 北京三元食品股份有限公司 复合益生菌及发酵乳在制备用于辅助治疗hiv患者产品中的应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002341384A1 (en) * 2001-09-05 2003-03-24 Actial Farmaceutica, Lda. Lactic acid bacteria comprising unmethylated cytosine-guanine dinucleotides for use in therapy
GB0124580D0 (en) * 2001-10-12 2001-12-05 Univ Reading New composition
FR2853908B1 (fr) * 2003-04-16 2005-06-03 Gervais Danone Sa Produit immunomodulateur obtenu a partir d'une culture de bifidobacterium et compositions le contenant
ATE414428T1 (de) * 2003-10-24 2008-12-15 Nutricia Nv Symbiotische zusammensetzung für kleinkinder
DE602004007813T2 (de) * 2004-08-05 2008-04-17 Anidral S.R.L. Folsäure produzierende bifidobacterium bakterienstämme, ihre formulierungen und verwendung
ITMI20042189A1 (it) * 2004-11-16 2005-02-16 Anidral Srl Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
KR100479719B1 (ko) * 2005-01-29 2005-03-31 주식회사 프로바이오닉 유해 병원성 미생물 생육 억제능 및 항알레르기성을 갖는 신규 내산성 락토바실러스 사케이 Ｐｒｏｂｉｏ-65
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
WO2008153377A1 (en) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
CN103263443B (zh) * 2007-12-07 2016-09-14 努特里希亚公司 用于尘螨变态反应的双歧杆菌
ES2398187T3 (es) 2009-01-28 2013-03-14 Metalquimia, Sa Unidad de tratamiento por convección forzada para tratar un producto cárnico cortado en rodajas, y procedimiento para preparar un producto cárnico usando dicha unidad
IT1400821B1 (it) * 2009-03-09 2013-07-02 Probiotical Spa Sospensione oleosa contenente batteri probiotici per uso pediatrico
US20110064777A1 (en) * 2009-09-11 2011-03-17 Sharad Mohan Live lactobacillus soap and method for delivering lactobacillus to skin tissue
IT1398553B1 (it) 2010-03-08 2013-03-01 Probiotical Spa Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario.

Also Published As

Publication number Publication date
US20130149342A1 (en) 2013-06-13
EP2626076A1 (en) 2013-08-14
PT2544698T (pt) 2016-07-15
DK2626076T3 (en) 2016-09-19
BR112012022755B1 (pt) 2021-03-02
PL2544698T3 (pl) 2017-08-31
HUE029245T2 (en) 2017-02-28
EP2544698B1 (en) 2016-05-04
ZA201207377B (en) 2015-04-29
CN103037876B (zh) 2015-04-01
EP2544698A1 (en) 2013-01-16
ES2603629T3 (es) 2017-02-28
RU2712751C2 (ru) 2020-01-31
PT2626076T (pt) 2016-10-04
JP6182628B2 (ja) 2017-08-16
BR112012022755A2 (pt) 2016-07-19
AU2011225798A1 (en) 2012-10-04
WO2011110918A1 (en) 2011-09-15
RU2012140052A (ru) 2014-04-20
RU2016129186A3 (it) 2019-11-21
PL2626076T3 (pl) 2017-08-31
AU2011225798B2 (en) 2017-02-02
WO2011110918A8 (en) 2011-11-10
ITMI20100375A1 (it) 2011-09-09
RU2712751C9 (ru) 2020-04-28
DK2544698T3 (en) 2016-07-04
KR20130018758A (ko) 2013-02-25
JP2016128502A (ja) 2016-07-14
US20170071989A1 (en) 2017-03-16
US8734783B2 (en) 2014-05-27
KR101872946B1 (ko) 2018-06-29
ZA201409369B (en) 2015-09-30
CA2792343C (en) 2019-04-02
ES2581803T3 (es) 2016-09-07
RU2016129186A (ru) 2018-12-10
JP2013521335A (ja) 2013-06-10
US20150017142A1 (en) 2015-01-15
UA111715C2 (uk) 2016-06-10
US9498503B2 (en) 2016-11-22
CN103037876A (zh) 2013-04-10
CN104800247A (zh) 2015-07-29
US9931363B2 (en) 2018-04-03
JP5931754B2 (ja) 2016-06-08
EP2626076B1 (en) 2016-08-24
HUE030888T2 (en) 2017-06-28
CA2792343A1 (en) 2011-09-15
RU2605293C2 (ru) 2016-12-20

Similar Documents

Publication Publication Date Title
IT1398553B1 (it) Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario.
IL278150A (en) A transgenic bacterium for the treatment of diseases related to hyperammonemia
ZA201707678B (en) Bacteria engineered to reduce hyperphenylalaninemia
HK1201208A1 (en) Probiotic bacteria
CL2013001316A1 (es) Composicion que comprende micro-organismo probioticos no replicantes que protegen contra las infecciones del tracto respiratorio superior.
DK3097919T3 (da) Bakterie til anvendelse som probiotika til ernæringsmæssige- og medicinske applikationer
HK1210018A1 (en) Tailored liposomes for the treatment of bacterial infections
AP2014007399A0 (en) Phenyl-3-AZA-bicycloÄ3.1.0Ühex-3-YL-methanones andthe use thereof as medicament
PT2809168T (pt) Bactérias probióticas microencapsuladas em multicamadas
PL3377518T3 (pl) Bakterie modyfikowane do celów zmniejszenia hiperfenyloalaninemii
PT3084009T (pt) Lactobacillus salivarius para o tratamento da mastite
BR112013011733A2 (pt) preparações de iorgurte consistentes contendo micro-organismos probióticos não replicativos
EP2768538A4 (en) ENHANCED BIOREGULATION VIA THE USE OF CHLORINE-AGENT STABILIZER MIXTURES
PL2758518T3 (pl) Nowe silnie termofilne bakterie rodzaju Caldicellulosiruptor
PL3027035T3 (pl) Wydzielające glukozę szczepy bakterii kwasu mlekowego
HK1210132A1 (en) Wastewater treatment for the production of microbial biomass
DK3068232T4 (da) Mælkesyrebakteriekultur
ZA201306342B (en) The treatment of viral infections
EP2970860A4 (en) GENETICALLY MODIFIED BACTERIA
EP2529728A4 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BACTERIAL INFECTIONS
TH1501006331A (th) องค์ประกอบที่มีแบคทีเรียที่อยู่ในจีนัสแลคโตบาซิลลัส
ITPN20110011U1 (it) Armadio perfezionato con sistema di aereazione
FI20115950A0 (fi) Probioottisia bakteereita sisältävä elintarvike
UA58160U (ru) Применение липофлавона в качесте средства для лечения черепно-мозговой травмы
GB201122449D0 (en) app81.com the bacteria detector app for smartphones